• SeekInCare™

    SeekInCare™ is the first-in-class blood-based pan-cancer early detection test.

    • panoramic view of cell-free cancer signatures in blood
    • multi-omics approach that incorporated genomic and epigenetic alterations in conjunction with protein biomarkers
    • Big data + AI


    Sample requirement: 10ml peripheral blood
    Test content: ctDNA mutation-centered
    Results readout: Cancer Risk Score (CRS) + Tissue Of Origin (TOO)

    Test workflow:

    Pre-test inquiry > Informed consent > Blood-draw > Testing > Analyzing + Interpretation > Reporting


    ©2018 SeekIn Cancer. All Rights Reserved.